3-(3-Amino-1H-indazol-4-ylethynyl)-N-[3-(4-methyl-piperazin-1-ylmethyl)-5-trifluoromethyl-phenyl]-benzamide

ID: ALA4780226

Chembl Id: CHEMBL4780226

PubChem CID: 155386684

Max Phase: Preclinical

Molecular Formula: C29H27F3N6O

Molecular Weight: 532.57

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(Cc2cc(NC(=O)c3cccc(C#Cc4cccc5[nH]nc(N)c45)c3)cc(C(F)(F)F)c2)CC1

Standard InChI:  InChI=1S/C29H27F3N6O/c1-37-10-12-38(13-11-37)18-20-15-23(29(30,31)32)17-24(16-20)34-28(39)22-6-2-4-19(14-22)8-9-21-5-3-7-25-26(21)27(33)36-35-25/h2-7,14-17H,10-13,18H2,1H3,(H,34,39)(H3,33,35,36)

Standard InChI Key:  QEWJRTUCCOIWLO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4780226

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L132 (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 532.57Molecular Weight (Monoisotopic): 532.2198AlogP: 4.56#Rotatable Bonds: 4
Polar Surface Area: 90.28Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.65CX LogP: 4.94CX LogD: 4.50
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.34Np Likeness Score: -1.61

References

1. El-Damasy AK,Jin H,Seo SH,Bang EK,Keum G.  (2020)  Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.,  207  [PMID:32961435] [10.1016/j.ejmech.2020.112710]

Source